Cargando…

Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation

BACKGROUND: T cell activation is associated with a rapid increase in intracellular fructose-2,6-bisphosphate (F2,6BP), an allosteric activator of the glycolytic enzyme, 6-phosphofructo-1-kinase. The steady state concentration of F2,6BP in T cells is dependent on the expression of the bifunctional 6-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Telang, Sucheta, Clem, Brian F, Klarer, Alden C, Clem, Amy L, Trent, John O, Bucala, Richard, Chesney, Jason
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441391/ https://www.ncbi.nlm.nih.gov/pubmed/22591674 http://dx.doi.org/10.1186/1479-5876-10-95

Ejemplares similares

Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism
por: Klarer, Alden C, et al.
Publicado: (2014)

6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27
por: Yalcin, A, et al.
Publicado: (2014)

A Novel Small Molecule Antagonist of Choline Kinase-α That Simultaneously Suppresses MAPK and PI3K/AKT Signaling
por: Clem, Brian F., et al.
Publicado: (2011)

Fructose-2,6-Bisphosphate synthesis by 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase 4 (PFKFB4) is required for the glycolytic response to hypoxia and tumor growth
por: Chesney, Jason, et al.
Publicado: (2014)

Simultaneous inhibition of the estrogen receptor and 6-phosphofructo-2-kinase (PFKFB3) for the treatment of ER+ breast cancer
por: Imbert-Fernandez, Yoannis, et al.
Publicado: (2014)

Targeting the sugar metabolism of tumors with a first-in-class 6-phosphofructo-2-kinase (PFKFB4) inhibitor
por: Chesney, Jason, et al.
Publicado: (2015)

Fructose-2,6-bisphosphate links glucose to survival and growth
por: Yalcin, Abdullah, et al.
Publicado: (2014)

Virus detection and identification using random multiplex (RT)-PCR with 3'-locked random primers
por: Clem, Amy L, et al.
Publicado: (2007)

Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma
por: Telang, Sucheta, et al.
Publicado: (2011)

Cytochrome c oxidase is activated by the oncoprotein Ras and is required for A549 lung adenocarcinoma growth
por: Telang, Sucheta, et al.
Publicado: (2012)

Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib
por: Telang, Sucheta, et al.
Publicado: (2014)

Targeting aspartate aminotransferase in breast cancer
por: Thornburg, Joshua Marshall, et al.
Publicado: (2008)

Evolution of Allosteric Citrate Binding Sites on 6-phosphofructo-1-kinase
por: Usenik, Aleksandra, et al.
Publicado: (2010)

Posttranslational Modification of 6-phosphofructo-1-kinase as an Important Feature of Cancer Metabolism
por: Šmerc, Andreja, et al.
Publicado: (2011)

Transient T cell depletion causes regression of melanoma metastases
por: Rasku, Mary Ann, et al.
Publicado: (2008)

Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase Modulates Oscillations of Pancreatic Islet Metabolism
por: Merrins, Matthew J., et al.
Publicado: (2012)

Balancing glycolytic flux: the role of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatases in cancer metabolism
por: Ros, Susana, et al.
Publicado: (2013)

The role of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 in esophageal squamous cell carcinoma
por: Bao, Junhui, et al.
Publicado: (2020)

Troglitazone suppresses tumor cell growth and glutamine metabolism through a PPAR-independent mechanism
por: Reynolds, Miriam, et al.
Publicado: (2014)

Overexpression of a modified 6-phosphofructo-1-kinase results in an increased itaconic acid productivity in Aspergillus niger
por: van der Straat, Laura, et al.
Publicado: (2013)

Effect of the cancer specific shorter form of human 6-phosphofructo-1-kinase on the metabolism of the yeast Saccharomyces cerevisiae
por: Andrejc, Darjan, et al.
Publicado: (2017)

Partial Inhibition of the 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase-3 (PFKFB3) Enzyme in Myeloid Cells Does Not Affect Atherosclerosis
por: Tillie, Renée J. H. A., et al.
Publicado: (2021)

Liver X Receptor α Is Involved in the Transcriptional Regulation of the 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase Gene
por: Zhao, Li-Feng, et al.
Publicado: (2012)

Increased expression and phosphorylation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoforms in urinary exosomes in pre-eclampsia
por: Ellis, R., et al.
Publicado: (2019)

6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoform 3 spatially mediates autophagy through the AMPK signaling pathway
por: Yan, Siyuan, et al.
Publicado: (2017)

Expression of Alternative Splice Variants of 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase-4 in Normoxic and Hypoxic Melanoma Cells
por: Trojan, Sonia E., et al.
Publicado: (2021)

RB in glutamine metabolism
por: Clem, Brian
Publicado: (2014)

The oncoprotein H-Ras(V12 )increases mitochondrial metabolism
por: Telang, Sucheta, et al.
Publicado: (2007)

6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase Suppresses Neuronal Apoptosis by Increasing Glycolysis and “cyclin-dependent kinase 1-Mediated Phosphorylation of p27 After Traumatic Spinal Cord Injury in Rats
por: Gao, Liansheng, et al.
Publicado: (2020)

6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer
por: Yi, Mei, et al.
Publicado: (2018)

Phosphofructo-1-Kinase Deficiency Leads to a Severe Cardiac and Hematological Disorder in Addition to Skeletal Muscle Glycogenosis
por: García, Miguel, et al.
Publicado: (2009)

Identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB4) as a Novel Autophagy Regulator by High Content shRNA Screening
por: Strohecker, Anne M., et al.
Publicado: (2015)

Monocarboxylate transporter 1 promotes classical microglial activation and pro-inflammatory effect via 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 3
por: Kong, Liang, et al.
Publicado: (2019)

Expression, regulation and function of phosphofructo-kinase/fructose-biphosphatases (PFKFBs) in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia cells
por: Carlet, Michela, et al.
Publicado: (2010)

Aspectos terapéuticos de la pedagogía Freinet/c/tr., José Cano Tembleque.
por: Berteloot, Clem
Publicado: (1980)

Fundamentals of Vaccine Immunology
por: Clem, Angela S
Publicado: (2011)

A Current Perspective on Leishmaniasis
por: Clem, Angela
Publicado: (2010)

The CMB-S3 landscape (15'+5)
por: Pryke , Clem
Publicado: (2016)

MEASURING A GOOD DEATH: AN ASSESSMENT ACROSS FOUR COUNTRIES
por: Clem, Sarah
Publicado: (2022)

Potential clinical and immunotherapeutic utility of talimogene laherparepvec for patients with melanoma after disease progression on immune checkpoint inhibitors and BRAF inhibitors
por: Chesney, Jason, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_arkg527kqpo4la9d965b1463p4